Search details
1.
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.
Cancer Sci
; 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38757410
2.
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 204(2): 612-622, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37857379
3.
First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
Br J Haematol
; 204(5): 1913-1919, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38420726
4.
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
Cytotherapy
; 2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38639671
5.
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.
Cytotherapy
; 26(2): 178-184, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38108686
6.
Scoring system for optimal cord blood unit selection for single cord blood transplantation.
Cytotherapy
; 26(3): 286-298, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38149949
7.
Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy.
Hematol Oncol
; 42(1): e3217, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37592904
8.
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
Ann Hematol
; 103(1): 285-296, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37947825
9.
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.
Am J Hematol
; 99(2): 263-273, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38164974
10.
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Jpn J Clin Oncol
; 54(2): 153-159, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-37986553
11.
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Haematologica
; 108(12): 3399-3408, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37470160
12.
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.
Cytotherapy
; 25(11): 1220-1228, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37341665
13.
Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
Hematol Oncol
; 41(1): 147-158, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36268564
14.
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database.
Ann Hematol
; 102(5): 1215-1227, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36918415
15.
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.
Ann Hematol
; 102(6): 1549-1559, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37126115
16.
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy.
Ann Hematol
; 102(10): 2879-2893, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37477669
17.
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Cytotherapy
; 24(10): 1013-1025, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35729020
18.
HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation.
Am J Hematol
; 97(3): 311-321, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34978726
19.
Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.
Am J Hematol
; 97(12): 1568-1579, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36087061
20.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol
; 192(1): 190-199, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33152120